Metabolic Reprogramming in Cancer

Authors

  • Isabel Vidal Valenzuela Spain

DOI:

https://doi.org/10.24310/enbio.v14i176.17260

Keywords:

Cancer, Cells

Abstract

This article reviews the molecular mechanisms that regulate the metabolism of cancer cells, as well as the possible therapeutic targets that could be exploited to interfere with their growth and survival. The article begins by explaining the Warburg effect, which is the preference of cancer cells for anaerobic glycolysis instead of oxidative respiration, even in the presence of oxygen. The article argues that this effect not only has an energetic purpose, but also a biosynthetic one, as it allows cancer cells to obtain the precursors necessary for the synthesis of lipids, nucleotides and proteins. Next, the article analyzes the intrinsic and extrinsic factors that contribute to metabolic reprogramming in cancer, such as mutations in oncogenic or tumor suppressor genes, the tumor microenvironment, inflammation and metabolic diseases. Finally, the article describes some of the therapeutic strategies that are being developed to inhibit or reverse metabolic reprogramming in cancer, such as inhibitors of glycolysis, glutaminolysis, lipogenesis and nucleotide biosynthesis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Serrano, J. J. (2012). Metabolismo y cáncer. Encuentros en la Biología 5 (138 – 139), 35 – 36.
Seth Nanda, C., Venkateswaran, S. V., Patani, N., & Yuneva, M. (2020). Defining a metabolic landscape of tumours: genome meets metabolism. British Journal of Cancer, 122(2), 136–149.
Sullivan, L. B., Gui, D. Y., Hosios, A. M., Bush, L. N., Freinkman, E. & Vander Heiden, M. G. (2015). Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162, 552–563.
Frezza C. (2020). Metabolism and cancer: the future is now. British Journal of Cancer, 122(2), 133–135.
Harris A. L. (2020). Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy. British Journal of Cancer, 122(1), 1–3.

Published

2021-03-21

How to Cite

Vidal Valenzuela, I. (2021). Metabolic Reprogramming in Cancer. Encuentros En La Biología, 14(176), 23–25. https://doi.org/10.24310/enbio.v14i176.17260

Issue

Section

Artículos